Latest News

Press Release
BOYDSense diabetes device places among top innovations at 2019 RESI Innovation Challenge
San Bruno, Calif. – October 29, 2019 – Medical technology company BOYDSense, Inc. has returned from the RESI (Redefining Early Stage Investments) conference in Boston with a second-place finish in the RESI Innovation Challenge and myriad accolades […]
From 38 Finalists. RESI Boston’s Audience Selects Innovation Challenge Champions
Boston, Mass. - September 12, 2019 - The RESI Innovation Challenge showcased 38 emerging startups in the biotech, medtech, diagnostics and digital health fields. All the competitors brought novel, exciting discoveries to the technology showcase […]


BOYDSense leaders speak about founding BOYDSense, its mission, the inspiration for the company name, the product, the technology, and more.

Ambrosia Investments and Jolt Capital are majority shareholders in BOYDSense’s parent company Alpha-MOS.


Here are a few of the honors we’ve received


For all media inquiries please email us at: